How Epicrispr is leveraging CRISPR without cutting DNA

Episode 195

0:00-33:03

This week we dive into the Beyond Biotech archive to bring you a discussion with Dr Stanley Qi, the founder of Epicrispr. Epicrispr is an epigenetic editing company, leveraging the power of CRISPR without cutting DNA. The company’s proprietary Gene Expression Modulation System (GEMS) includes the smallest Cas protein known to work in human cells, enabling in vivo or ex vivo delivery via a single viral vector. In this episode we discuss epigenetic editing, why it’s reversible, and how it can treat FSHD and other conditions. 01:43 Meet Stanley Qi 03:32 Founding Epicrispr 05:53 CRISPR interference and epigenome explained 10:04 Overview of GEMS gene modulation system 11:28 Reversibility and safety of epigenetic edits 18:42 Strategy for tackling multiple disease conditions 23:27 Clinical trial plans for EPI-321 candidate 30:06 Looking forward This episode is brought to you with the support of MedChemExpress. Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here! Stay updated by subscribing to our newsletter To dive deeper into the topic: Could CRISPR really cure these diseases? 10 gene therapy companies you should know about CRISPR technology’s next wave: Ten companies to watch

Publisher

Beyond Biotech - the podcast from Labiotech

Published

April 30, 2026

Duration

33 min

Format

Podcast

Category

Issues · Tech News

Source

RSS feed

Host

Labiotech

BB

Beyond Biotech - the podcast from Labiotech

@beyondbiotechthepodcastfroml

#epicrispr #leveragingcrispr #cuttingdna

The Nile